SCHEMBL7009318

SCHEMBL7009318

COC(=O)COc1cccn2cc(C3CC3)cc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42
PLA2G1B P04054 3/20 0.42
LMNA P02545 1/20 0.41
KDM4E B2RXH2 4/20 0.39
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PLA2G2A P14555 1/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AR P10275 1/20 0.35
CYP1A2 P05177 1/20 0.35
PPARD Q03181 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013826 0.95 PTGDR2 (0.48) PTGDRPTGDR2PLA2G1BLMNAKDM4E
SCHEMBL7012342 0.81 LMNA (0.46) PLA2G1BLMNAKDM4EPOLBMAPT
SCHEMBL7009518 0.79 SUV39H2 (0.37) KDM4EMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL7006564 0.79 LMNA (0.43) PLA2G1BLMNAKDM4EPOLBMAPT
SCHEMBL7011741 0.78 LMNA (0.43) PLA2G1BLMNAKDM4EPOLBMAPT
SCHEMBL7013866 0.78 LMNA (0.43) PLA2G1BLMNAKDM4EPOLBMAPT
SCHEMBL27159577 0.72 PTGDR2 (0.61) PTGDRPTGDR2LMNAKDM4EDDB1
SCHEMBL7006601 0.72 PLA2G1B (0.49) PTGDRPTGDR2PLA2G1BALDH1A1MEN1
SCHEMBL7006598 0.70 PTGDR2 (0.48) PTGDRPTGDR2PLA2G1BLMNAALDH1A1
SCHEMBL7014306 0.70 PLA2G1B (0.61) PTGDRPTGDR2PLA2G1BALDH1A1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed